PortfoliosLab logoPortfoliosLab logo
ISIN
US0144421072
CUSIP
014442107
IPO Date
Feb 7, 2019

Highlights

Market Cap
$215.65M
Enterprise Value
$183.85M
EPS (TTM)
-$1.20
Total Revenue (TTM)
$18.42M
Gross Profit (TTM)
$15.11M
EBITDA (TTM)
-$118.57M
Year Range
$1.09 - $3.40
Target Price
$2.00
ROA (TTM)
-52.26%
ROE (TTM)
-1,207.74%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Alector, Inc.

Performance

ALEC Performance Chart

Alector, Inc. (ALEC) is up 25.0% since the beginning of the year. At $2 per share, ALEC is trading 42.6% below its 52-week high of $3. Investors who bought $1,000 worth of ALEC shares 5 years ago would now be looking at an investment worth $100.


Loading charts...

S&P 500 Index

Returns By Period

Alector, Inc. (ALEC) has returned 25.00% so far this year and 41.30% over the past 12 months.


Alector, Inc.

1D
-5.80%
1M
-17.37%
YTD
25.00%
6M
71.05%
1Y
41.30%
3Y*
-35.06%
5Y*
-36.95%
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALEC Monthly Returns History

Based on dividend-adjusted daily data since Feb 7, 2019, ALEC's average daily return is +0.02%, while the average monthly return is -0.48%.

Historically, 44% of months were positive and 56% were negative. The best month was Jan 2020 with a return of +62.2%, while the worst month was Oct 2025 at -50.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, ALEC closed higher 50% of trading days. The best single day was Jul 2, 2021 with a return of +57.1%, while the worst single day was Oct 22, 2025 at -49.8%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202621.15%28.57%-11.52%10.23%-8.86%-9.72%25.00%
2025-12.17%-1.20%-25.00%-2.44%10.83%5.26%6.43%57.72%25.96%-50.34%-9.52%17.29%-17.46%
2024-25.31%16.95%-13.63%-15.61%-3.15%-7.72%32.16%-12.00%-11.74%5.58%-47.36%-27.03%-76.32%
2023-4.44%-3.17%-27.52%6.62%12.73%-19.22%14.14%-20.55%18.90%-19.75%4.23%47.23%-13.54%
2022-23.20%-0.13%-10.04%-32.63%-7.71%14.67%0.59%1.27%-8.60%-2.75%-7.72%8.72%-55.30%
202111.30%7.96%10.78%-3.18%-8.72%17.02%15.39%12.46%-15.58%-4.73%-5.01%-0.00%36.48%

Benchmark Metrics

Alector, Inc. has an annualized alpha of -17.06%, beta of 1.48, and R2 of 0.12 versus S&P 500 Index. Calculated based on daily prices since February 08, 2019.

  • This stock participated in 130.23% of S&P 500 Index downside but only -14.02% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.12 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-17.06%
Beta
1.48
0.12
Upside Capture
-14.02%
Downside Capture
130.23%

Return for Risk

Risk / Return Rank

ALEC ranks 57 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.


ALEC Risk / Return Rank: 5757
Overall Rank
ALEC Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
ALEC Sortino Ratio Rank: 6060
Sortino Ratio Rank
ALEC Omega Ratio Rank: 6565
Omega Ratio Rank
ALEC Calmar Ratio Rank: 5454
Calmar Ratio Rank
ALEC Martin Ratio Rank: 5252
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Alector, Inc. (ALEC) and compare them to S&P 500 Index.


ALECBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.41

2.39

-1.98

Sortino ratio

Return per unit of downside risk

1.29

3.25

-1.96

Omega ratio

Gain probability vs. loss probability

1.20

1.43

-0.24

Calmar ratio

Return relative to maximum drawdown

0.63

3.11

-2.48

Martin ratio

Return relative to average drawdown

1.17

14.38

-13.21

Dividends

Dividend History


Alector, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Alector, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alector, Inc. was 97.71%, occurring on Apr 10, 2025. The portfolio has not yet recovered.

The current Alector, Inc. drawdown is 95.06%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-97.71%Apr 2025
3y 9mo
4y 11moJul 2021 - now
2020 bear market2020
-73.36%Oct 2020
8mo 13d8mo 19d
1y 4moFeb 2020 - Jul 2021
2019 bear market2019
-46.37%Oct 2019
5mo 27d3mo 23d
9mo 20dApr 2019 - Jan 2020
2019 bear market2019
-29.02%Mar 2019
14d24d
1mo 8dFeb 2019 - Apr 2019
2019 pullback2019
-9.44%Feb 2019
0s5d
5dFeb 2019 - Feb 2019

Drawdown Indicators


ALECBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-97.71%

-56.78%

-40.93%

Max Drawdown (1Y)

Largest decline over 1 year

-65.66%

-9.10%

-56.56%

Max Drawdown (3Y)

Largest decline over 3 years

-89.69%

-18.90%

-70.79%

Max Drawdown (5Y)

Largest decline over 5 years

-97.71%

-25.43%

-72.28%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-95.06%

0.00%

-95.06%

Average Drawdown

Average peak-to-trough decline

-65.89%

-10.72%

-55.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.31%

1.97%

+33.34%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Alector, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Alector, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for ALEC relative to other companies in the Biotechnology industry. Currently, ALEC has a P/S ratio of 11.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for ALEC in comparison with other companies in the Biotechnology industry. Currently, ALEC has a P/B value of 20.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with ALEC

Add Alector, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with ALEC